Altimmune, Inc.
ALT$469M
Small CapNASDAQPharmaceutical Preparations🇺🇸North AmericaGAITHERSBURG
Drugs in Pipeline
3
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
May 15, 2026
9wMarket Overview
Stock performance and key metrics
ALT News
Catalyst Timeline
1 upcoming, 0 past
Drug Pipeline
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
ALT-801 | Phase 2 | Obesity/Overweight | - | - |
Pemvidutide | Phase 2 | Alcohol Use Disorder (AUD) | - | - |
NasoVAX | Phase 2 | Influenza | - | - |
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply